The MVI immunotherapy solution involves two components:
We are working to delay time to metastases, and thus time to initiation of castration therapies, to preserve each patient's quality of life.
We have clinical trials in progress that are targeting:
We are always looking to speak and partner with clinicians working to offer their patients treatment regimens that will help maintain quality of life. We welcome you to get in touch.